Lester wrote:

I came across this post Monday.

"Scientists for the Food and Drug Administration say an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug failed to extend life and carried significant side effects."

Would anyone care to comment?